Filter
161
Text search:
antipsychotic
Featured
Recommendations
29
New Publications
24
Language
Document type
No document type
120
Guidelines
16
Manuals
10
Studies & Reports
7
Fact sheets
4
Training Material
2
Brochures
1
Resource Platforms
1
Countries / Regions
Ethiopia
8
South Africa
4
Global
4
India
3
Western and Central Europe
3
Eastern Europe
3
Zimbabwe
2
Nepal
2
Kenya
2
Jamaica
2
Sierra Leone
1
Nigeria
1
Ghana
1
South Sudan
1
Afghanistan
1
Zambia
1
Syria
1
Bangladesh
1
Brazil
1
Ukraine
1
Botswana
1
Latin America and the Carribbean
1
Eastern Europe and Central Asia
1
Paraguay
1
Asia
1
Venezuela
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
28
Clinical Guidelines
8
Public Health
6
Capacity Building
1
Pharmacy & Technologies
1
Toolboxes
Mental Health
121
Pharmacy
8
COVID-19
3
NCDs
3
Conflict
2
TB
2
Global Health Education
2
Planetary Health
2
Disability
1
Natural Hazards
1
HIV
1
Caregiver
1
Other disorders
Chapter H.5.1
Q5.SCOPING QUESTION: In individuals with psychotic disorders (including schizophrenia) who require long-term antipsychotic treatment, what is the safety and role of depot antipsychotic medication?
Q2: In individuals with psychotic disorders (including schizophrenia), is the use of two or more antipsychotic medications concurrently more effective and safer than the use of one antipsychotic onl
...
Second-generation antipsychotic medications for psychotic disorders (including schizophrenia)
recommended
Q14. SCOPING QUESTION: In adults with psychotic disorders (including schizophrenia), what is the comparative effectiveness and safety of second-generation antipsychotic medications?
Q6: In individuals with psychotic disorders (including schizophrenia) who require long term antipsychotic treatment, are anticholinergic medications more effective in preventing or reducing extrapyramidal side-effects and/or improving treatment adhe
...
Q1: In individuals with psychotic disorders (including schizophrenia), are antipsychotic drugs safe and effective?
Q3: In individuals with a first psychotic episode with full remission, how long should antipsychotic drug treatment be continued after remission in order to allow for the best outcomes?
Q4: In individuals with long term and/or recurrent psychotic disorders (including schizophrenia), should individuals be maintained on pharmacotherapy indefinitely or withdrawn from treatment in order to allow for the best outcomes?
Q7: In individuals with bipolar mania, are a) antipsychotics, b) mood stabilizers (lithium carbonate, valproate, and carbamazepine) effective and safe
The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalised anxiety and sleep disorders; obsessive-compulsive disorders and panic attacks; and alcohol and opioid dependence
Clinical Guideline
Schizophr Bull. 2014 Jan;40(1):192-213. doi: 10.1093/schbul/sbs150. Epub 2012 Dec 17.
Q3: For behavioural and psychological symptoms in people with dementia, do following drugs, when compared to placebo/comparator, produce benefits/harm in the specified outcomes?
This guide was developed by AACAP to give reliable information about medication
used to treat bipolar disorder in children and adolescents to parents whose children
have been diagnosed with the illness.
Other disorders
Chapter H.5
Accessed April 16, 2019
WHO mhGAP Guideline update
recommended
Update of the Mental Health Gap Action Programme
(mhGAP) Guideline for Mental, Neurological and Substance use Disorders May 2015
Q15. SCOPING QUESTION: Is pharmacological intervention effective and safe for treatment of psychotic disorders in adolescents (including schizophrenia and bipolar disorder)?
Reduced healthy life expectancy due to the high burden of both mental ill health and noncommunicable diseases (NCDs) is a major public health concern in the European Region. The links between mental disorders and major NCDs are well established.
In clinical practice, however, mental disorders in pa
...
